Selinexor in Combination with SVd Induces a High Response Rate in Patients with RMM
Selinexor in Combination with Weekly Low Dose Bortezomib and Dexamethasone (SVd) Induces a High Response Rate with Durable Responses in Patients with Refractory Multiple Myeloma (MM)<br /><br />Nizar J. Bahli...
Author: InternationalMyelomaFoundation
Added: 01/16/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts